Forecast: Hospital Discharges for Leiomyoma of Uterus in Canada

In 2023, the rate of hospital discharges for leiomyoma of the uterus in Canada was 45.2 per hundred thousand persons. The forecasted data for 2024 to 2028 shows a declining trend, starting at 43.8 and decreasing to 38.5. The year-on-year percentage change indicates a consistent decline, with approximately 3.4% on average annually. The compound annual growth rate (CAGR) over the five-year period is expected to reflect a steady decrease, illustrating ongoing improvements in medical management or shifting demographic factors.

Future trends to watch for include advancements in non-surgical interventions and public health measures that may further reduce hospital discharge rates. Additionally, monitoring demographic shifts and healthcare policy changes will be crucial in understanding long-term projections.

Top Countries about Genitourinary System Disease